metastatic isiri diki cell lung cancer kurapwa

Metastatic isiri-diki cell lung cancer (mnsclc) Chirwere chakaomarara chinoda kuti hurongwa hwakarongeka hwekurapa. Iyi gwara inopa kutarisisa kweazvino sarudzo dzekurapa, kusanganisira dzakatarwa marapirwo, nemhirizhonga, uye miedzo yemhuri, nemhuri dzeruzivo kuti dzizivise metastin is-diki cell cancerMetastatic isiri-diki cell lung cancer, anozivikanwawo seStage IV NSCLC, zvinoreva cancer yakapararira kubva kumapapu kune dzimwe nhengo dzemuviri. SITESS SITESS yeMetastasis inosanganisira uropi, mapfupa, chiropa, uye adrenal gland. Nepo cancer yemberi inogona kuve yakaoma kurapa, kufambira mberi mukurapwa sarudzo kune zvinovandudzwa zvibodzwa uye hupenyu hwehupenyu hwevarwere vazhinji. Kuongororwa kwekutanga kwakakosha, uye unogona kudzidza zvakawanda nezve kutsvagisa cancer kuShandong Baofcer Adenoarcinoma ndiyo inowanzoitika mhando uye kazhinji inoitika muvasina kuputa. Squamous Cell Carcinoma inowanzobatana nekuputa. Mamwe marudzi mashoma akajairika anosanganisira yakakura cell carcinoma uye adenosquamous cinooma. Kuongororwa kwakaringana kweiyo subtype kwakakosha pakusarudza nzira inoshanda kwazvo yekurapa .. metastatic isiri diki cell lung cancer kurapwa Kazhinji zvinosanganisira kusanganiswa kwekufungidzira bvunzo (CT SCAN, PET SCANS, MRI), Biopsies, uye kuongororwa kwemanyorerwo. MOLECULARDING inoongorora cancer masero ezvakananga genetic kana biomarkers idzo dzinogona kunangwa nezvakanyanya kurapa. Staging anotanga kuparadzira kenza yakapararira, achibatsira vanachiremba Talor The Creatment Planc.tragment Sarudzo dzeMetastatic Isiri Diki Cell Cell Cell Cell Cell Cell metastatic isiri diki cell lung cancer kurapwa inowanzove systemic, zvinoreva kuti inokanganisa muviri wese. Zviitiko zvakajairika kurapwa zvinosanganisira: zvakanangwa zvirema zvekurapa zvekurapa zvinodhaka zvinonyatso tarisa mamwe mamorekuru (semapuroteni kana majini) anobatsira cancer masero kukura nekupararira. Aya marapirwo anowanzoshandiswa mune varwere vane mhandara ine mitezo.egfr Inhibitremidermal Kukura (Egfr) Inhibitors inoshandiswa kune varwere vane EGF kuzvinyengeri. Zvakajairika EGFR Inhitors inosanganisira: osimertinib (tagsso) erlotinib (tarceva) efitinib (glotenzi) eAnfbitarsanapastic Lymphoma. Commen Inhbitors inosanganisira: Alecensa) Brigatinib (Alunbrig) Ceritinib (Zykadig) Cancer Yako Oncologist ichaona kana cancer yako ine chero yezvigadzirwa izvi.immunotherapyimmunotsurapy mishonga inobatsira immune system yako yekuziva uye kurwisa cancer masero. Aya marapirwo ekurapa anowanzoshandiswa seyekutanga-mutsara kurapwa sarudzo ye metastatic isiri diki cell lung cancer kurapwa.PD-1 uye PD-L1 InhibitorsE mishonga inovharira iyo PD-1 (yakarongedzwa cell Deful ligand 1) mapuroteni, ayo anobatsira cancer masero anodzosera immune system. Common PD-1 nePD-L1 Inhibitors Inosanganisira: Pembrollizumab (Keytruda) NVCLUMABABAR (THECENCE) . Ipilimumab (Yervoy) is a common CTLA-4 inhibitor, sometimes used in combination with PD-1 inhibitors.ChemotherapyChemotherapy drugs use powerful chemicals to kill cancer cells. Nepo tarisa kurapa uye immunomothapige zvakazara, chemotherapy inoramba iri nzira yekurapa yekurapa, kunyanya mukusanganiswa nevamwe kurapwa. Commoterapy mishonga inoshandiswa metastatic isiri diki cell lung cancer kurapwa Sanganisira: Platinum-based mishonga (Cisplatin, carboplatin) Taxanes (Pacetaxel) Pemzar Kazhinji inoshandiswa kudzikisira zviratidzo zvakadai sekurwadziwa kana kupfupika kana kenza ikapararira kunzvimbo dzakananga senge pfupa kana uropi. Inogona zvakare kushandiswa kurapa iyo yepuraimari yemapapu.feurgerysurgery kazhinji haisi iyo yekutanga kurapwa kwe metastatic isiri diki cell lung cancer kurapwa, asi inogona kushandiswa mune mamwe mamiriro kubvisa imwe messasis, kunyanya muuropi kana adrenal glass. Izvi zvinowanzoitika chikamu chehurongwa hwakakwana hwekurapa.clinal yemiedzo yemiedzo yezviitiko zvekutsvagisa zvinoedza kurapwa kwehunyanzvi. Ivo vanopa varwere kuwana mukana wekucheka-kumucheto marapirwo ausina kuwanikwa zvakanyanya. Funga nezvekukurukura nezvechiriniki nzira dzekuyedza nachiremba wako. Shandong baofcer Research Institute anoshingairira anotora chikamu uye anokurudzira kugona kweKrisini.Masa Side Mhedzisiro Kurapa kunogona kukonzera mhedzisiro. Chiremba wako anogona kukubatsira iwe kubata aya mhedzisiro nemishonga uye kumwe kutsigirwa. Mamiriro ezvinhu akafanana anosanganisira kupera simba, kusvotwa, kurwadziwa, uye kurasikirwa kwebvudzi. Izvo zvakakosha kutaurirana chero mhedzisiro yaunosangana neyako yehutano hwehutano hwekuchengeta. metastatic isiri diki cell lung cancer kurapwa Kusiyana zvichienderana nezvinhu zvinoverengeka, kusanganisira iyo nhanho yekenza, hutano hwese hwemurwere, uye kurapwa kwakananga kwakatambirwa. Kunyange chirwere ichi chinowanzoitika Kurukura kwako prognosis yako nepocologist yako Inogona kupihwa chero chikamu chechirwere, uye zvinowanzoshandiswa pamwe chete nezvokuita zvimwe zvirimwa. Palliative hanya inogona kubatsira kurwadzisa kurwadziwa, kupfupika kwekufema, kuneta, uye zvimwe zviratidzo.Ke kufunga kwekurapa kwekurapa kurapwa kwakaringana kwe metastatic isiri diki cell lung cancer kurapwa chisarudzo chakaomarara chinofanira kuitwa mukubvunzurudzwa neako oncologist yako. Heano mamwe mafungiro akakosha: Molecular Kuedza Mhedzisiro: Kunzwisisa iyo chaiyo genetic shanduro kana biomarkers mumasero ematehwe ako akakosha pakusarudza kana zvakanangwa kurapa sarudzo. Hutano hwese: Hutano hwako hwese uye huwandu hwekusimba huchasimbisa izvo kurapwa kwakakodzera. Zvinangwa Zvekurapa: Kurukura zvinangwa zvako kuti uratidze nachiremba wako, kungave kwekuwedzera kupona, kugadzirisa hupenyu hwehupenyu, kana zvese zviri zviviri. Mhedzisiro: Nzwisisa mhedzisiro inogona kuitika yeimwe nzira yekurapa uye kuti vangatungamirirwa sei. Miedzo yeKririniki: Funga kuti kutora chikamu mumhirizhonga mumutambo wekiriniki kwakakodzera iwe. New kurapa uye nzira dzinogara dzichikura. Zvimwe zvekufambira mberi zvinobudirira zvinosanganisira: Antibody-zvinodhaka conjugates (adcs): Izvi zvinodhaka zvinosanganisa chaizvo kurapa kwakanangidzirwa neyekuuraya masero simba remakemotherapy. Bispecific Antibodies: Aya antiboboy anoshandisa masero masero ekutarisa uye kuuraya cancer cancer. Yakavandudzwa Radiation Maitiro: Maitiro kunge stereotic muviri radiation kurapwa metastatic isiri diki cell lung cancer kurapwa Zvinogona kuve zvakaoma, asi kune zvakawanda zviwanikwa zviripo kubatsira varwere nemhuri dzavo. Mapoka ekutsigira, zano, uye nharaunda dzekumamhepo dzinogona kupa kutsigira kwepamoyo uye zano rinoshanda. Kuchengeta mararamiro ane hutano, kusanganisira kudya kwakaringana uye kugara uchiita kurovedza muviri, kunogona kuvandudza hupenyu hwehupenyu. Disiki: Ruzivo urwu rwunoitirwa ruzivo rwevanhu uye zvinangwa ruzivo chete, uye hazviite zano rekurapa. Izvo zvakakosha kuti ubvunze nehutano hunokodzera hwehutano hwehutano hwehutano hwekunetseka kana usati waita chero sarudzo zvine chekuita nehutano hwako kana kurapwa.Zvekunze zviwanikwa:American Cancer Society - Kurapa isiri-diki cell lung cancer nechidimbuCancer.net - Lung cancer - isiri-diki sero - kurapwa sarudzoNational Comprehensive Cancer Network (NCCN) - Non-Small Cell Lung Cancer Guidelines for Patients (PDF)Mareferensi: Dhata uye ruzivo rwunoratidzwa zvakavakirwa pane ruzivo rwekurapa rwazvino uye rwakatwasuka kubva kumasangano ane mukurumbira wekurapa kubva kuna Gumiguru 26, 2023.